1. Home
  2. WRBY vs NVAX Comparison

WRBY vs NVAX Comparison

Compare WRBY & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRBY
  • NVAX
  • Stock Information
  • Founded
  • WRBY 2010
  • NVAX 1987
  • Country
  • WRBY United States
  • NVAX United States
  • Employees
  • WRBY N/A
  • NVAX N/A
  • Industry
  • WRBY Ophthalmic Goods
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WRBY Health Care
  • NVAX Health Care
  • Exchange
  • WRBY Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • WRBY 1.9B
  • NVAX 2.0B
  • IPO Year
  • WRBY 2021
  • NVAX 1995
  • Fundamental
  • Price
  • WRBY $17.23
  • NVAX $9.90
  • Analyst Decision
  • WRBY Buy
  • NVAX Buy
  • Analyst Count
  • WRBY 8
  • NVAX 6
  • Target Price
  • WRBY $16.88
  • NVAX $17.83
  • AVG Volume (30 Days)
  • WRBY 1.4M
  • NVAX 7.2M
  • Earning Date
  • WRBY 11-07-2024
  • NVAX 11-07-2024
  • Dividend Yield
  • WRBY N/A
  • NVAX N/A
  • EPS Growth
  • WRBY N/A
  • NVAX N/A
  • EPS
  • WRBY N/A
  • NVAX N/A
  • Revenue
  • WRBY $719,929,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • WRBY $15.94
  • NVAX N/A
  • Revenue Next Year
  • WRBY $13.07
  • NVAX N/A
  • P/E Ratio
  • WRBY N/A
  • NVAX N/A
  • Revenue Growth
  • WRBY 13.67
  • NVAX N/A
  • 52 Week Low
  • WRBY $9.83
  • NVAX $3.53
  • 52 Week High
  • WRBY $18.37
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • WRBY 57.79
  • NVAX 36.20
  • Support Level
  • WRBY $16.71
  • NVAX $9.52
  • Resistance Level
  • WRBY $17.86
  • NVAX $10.63
  • Average True Range (ATR)
  • WRBY 0.66
  • NVAX 0.57
  • MACD
  • WRBY 0.01
  • NVAX -0.12
  • Stochastic Oscillator
  • WRBY 62.77
  • NVAX 9.97

About WRBY Warby Parker Inc.

Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: